Eli Lilly's Zepbound Receives FDA Approval for Moderate-to-Severe OSA and Obesity
CompanyDrug

Eli Lilly’s Zepbound Receives FDA Approval for Moderate-to-Severe OSA and Obesity

Novo Nordisk's Alhemo Receives FDA Approval for Hemophilia A and B Prophylaxis
CompanyDrug

Novo Nordisk’s Alhemo Receives FDA Approval for Hemophilia A and B Prophylaxis

Boehringer Ingelheim-SEC Joint Incubator Launches in Shenzhen's Luohu District
Company

Boehringer Ingelheim-SEC Joint Incubator Launches in Shenzhen’s Luohu District

CStone Pharmaceuticals Initiates First-in-Human Trial for PD-1/VEGF/CTLA-4 Trispecific Antibody CS2009
CompanyDrug

CStone Pharmaceuticals Initiates First-in-Human Trial for PD-1/VEGF/CTLA-4 Trispecific Antibody CS2009

Becton, Dickinson and Co. Launches RMB1.332 Billion Factory in Jiangsu for Pre-Filled Syringes
CompanyMedical Device

Becton, Dickinson and Co. Launches RMB1.332 Billion Factory in Jiangsu for Pre-Filled Syringes

C.Q. Pharmaceutical Holding to Come Under SASAC's Indirect Control via Genertec Acquisition
CompanyDeals

C.Q. Pharmaceutical Holding to Come Under SASAC’s Indirect Control via Genertec Acquisition

Yifan Pharmaceutical's Evive Biotech Receives ANVISA Approval for Ryzneuta
CompanyDrug

Yifan Pharmaceutical’s Evive Biotech Receives ANVISA Approval for Ryzneuta

Changchun BCHT Biotechnology Receives NMPA Approval for HSV-2 mRNA Vaccine LVRNA101
CompanyDrug

Changchun BCHT Biotechnology Receives NMPA Approval for HSV-2 mRNA Vaccine LVRNA101

Shenzhen Chipscreen Biosciences Gets NMPA Approval for CS231295 Solid Tumor Study
CompanyDrug

Shenzhen Chipscreen Biosciences Gets NMPA Approval for CS231295 Solid Tumor Study

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials

CSPC Pharmaceutical's SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial
CompanyDrug

CSPC Pharmaceutical’s SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial

CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates
CompanyDrug

CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates